Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

Abstract

Background: Although there are many studies of the predictors of death in hepatocellular carcinoma (HCC), most combine patients with and without cirrhosis and many combine those with compensated and decompensated cirrhosis. Objective: To perform a systematic review of the literature evaluating the predictors of death in patients with cirrhosis and HCC and to evaluate whether the predictors differ between patients with compensated and decompensated cirrhosis. Methods: Inclusion criteria: (i) publication in English, (ii) adult patients, (c) >80% of the patients had cirrhosis, (iv) follow‐up >6 months and (v) multivariable analysis. Quality was based on the accepted quality criteria for prognostic studies. Results: Of the 1106 references obtained, 947 were excluded because they did not meet the inclusion criteria. A total of 23 968 patients were included in 72 studies (median, 177/study); 77% male, median age 64, 55% Child–Pugh class A. The most robust predictors of death were portal vein thrombosis, tumour size, α‐foetoprotein and Child–Pugh class. Sensitivity analysis using only 15 ‘good’ studies and 22 studies in which all patients had cirrhosis yielded the same variables. In the studies including mostly compensated or decompensated patients, the predictors were both liver and tumour related. However, these studies were few and the results were not robust. Conclusions: This systematic review of 72 studies shows that the most robust predictors of death in patients with cirrhosis and HCC are tumour related and liver related. Future prognostic studies should include these predictors and should be performed in specific patient populations to determine whether specific prognostic indicators are more relevant at different stages of cirrhosis.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 89

1. 1.

   Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463-72.

   Not in our library10.1053/gast.1997.v112.pm9024300

2. 2.

   D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-31.

   Not in our library10.1016/j.jhep.2005.10.013

3. 3.

   Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-2.

   Not in our library10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e

4. 4.

   A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28:751-5.

   Not in our library10.1002/hep.510280322

5. 5.

   Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-38.

   Not in our library10.1055/s-2007-1007122

6. 6.

   Diamond GA. Future imperfect: the limitations of clinical prediction models and the limits of clinical prediction. J Am Coll Cardiol. 1989;14(Suppl. A):12A-22A.

   Not in our library10.1016/0735-1097(89)90157-5

7. 7.

   Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277:488-94.

   Not in our library

8. 8.

   Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130:515-24.

   Not in our library10.7326/0003-4819-130-6-199903160-00016

9. 9.

   Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-9.

   Not in our library10.1056/nejm199603143341104

10. 10.

    Calvet X, Bruix J, Gines P, et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology. 1990;12(Part 1):753-60.

    Not in our library10.1002/hep.1840120422

11. 11.

    Akashi Y, Koreeda C, Enomoto S, et al. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology. 1991;14:262-8.

    Not in our library

12. 12.

    Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology. 1992;16:132-7.

    Not in our library10.1002/hep.1840160122

13. 13.

    Nomura F, Ohnishi K, Honda M, et al. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer. 1994;70:690-3.

    Not in our library10.1038/bjc.1994.374

14. 14.

    Pirisi M, Fabris C, Soardo G, et al. Prognostic value of serum alpha-1-antitrypsin in hepatocellular carcinoma. Eur J Cancer. 1996;32A:221-5.

    Not in our library10.1016/0959-8049(95)00542-0

15. 15.

    Yamashita F, Tanaka M, Satomura S, Tanikawa K. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology. 1996;111:996-1001.

    Not in our library10.1016/s0016-5085(96)70067-7

16. 16.

    Kouroumalis EA, Skordilis PG, Moschandrea J, et al. Natural history of advanced hepatocellular carcinoma in Crete. Association with hepatitis C virus. Eur J Gastroenterol Hepatol. 1997;9:981-8.

    Not in our library10.1097/00042737-199710000-00011

17. 17.

    Shiota G, Kishimoto Y, Suyama A, et al. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. J Hepatol. 1997;27:661-8.

    Not in our library10.1016/s0168-8278(97)80083-9

18. 18.

    Tanizaki H, Ryu M, Kinoshita T, et al. Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol. 1997;27:67-70.

    Not in our library10.1093/jjco/27.2.67

19. 19.

    Ebara M, Hatano R, Fukuda H, et al. Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepatogastroenterology. 1998;45(Suppl. 3):1214-20.

    Not in our library

20. 20.

    Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol. 1998;21:386-91.

    Not in our library10.1097/00000421-199808000-00014

21. 21.

    Chevret S, Trinchet JC, Mathieu D, et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol. 1999;31:133-41.

    Not in our library10.1016/s0168-8278(99)80173-1

22. 22.

    Hayashi K, Kumada T, Nakano S, et al. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol. 1999;94:3028-33.

    Not in our library10.1111/j.1572-0241.1999.01378.x

23. 23.

    Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-7.

    Not in our library10.1002/hep.510290145

24. 24.

    Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology. 2000;31:840-5.

    Not in our library10.1053/he.2000.5628

25. 25.

    Dohmen K, Shirahama M, Onohara S, et al. Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients. Hepatol Res. 2000;18:110-21.

    Not in our library10.1016/s1386-6346(99)00094-7

26. 26.

    Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer. 2000;89:2266-73.

    Not in our library

27. 27.

    Giannini E, Arzani L, Borro P, et al. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepatogastroenterology. 2000;47:1395-8.

    Not in our library

28. 28.

    Tangkijvanich P, Janchai A, Charuruks N, et al. Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma. Asian Pac J Allergy Immunol. 2000;18:237-43.

    Not in our library

29. 29.

    Farinati F, Gianni S, Marin G, et al. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis? Eur J Gastroenterol Hepatol. 2001;13:1217-24.

    Not in our library10.1097/00042737-200110000-00015

30. 30.

    Lerose R, Molinari R, Rocchi E, Manenti F, Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer. 2001;37:239-45.

    Not in our library10.1016/s0959-8049(00)00354-3

31. 31.

    Schoniger-Hekele M, Muller C, Kutilek M, et al. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut. 2001;48:103-9.

    Not in our library10.1136/gut.48.1.103

32. 32.

    Shiomi S, Nishiguchi S, Ishizu H, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol. 2001;96:1877-80.

    Not in our library10.1111/j.1572-0241.2001.03888.x

33. 33.

    Toyoda H, Kumada T, Nakano S, et al. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer. 2001;91:957-63.

    Not in our library

34. 34.

    Ueno S, Tanabe G, Sako K, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology. 2001;34:529-34.

    Not in our library10.1053/jhep.2001.27219

35. 35.

    Giannelli G, Pierri F, Trerotoli P, et al. Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res. 2002;24:50.

    Not in our library10.1016/s1386-6346(02)00027-x

36. 36.

    Giannini E, Romagnoli P, Fasoli A, et al. Influence of age on clinical presentation, therapeutic options, and prognosis in anti-HCV positive cirrhotic patients with hepatocellular carcinoma. Age Ageing. 2002;31:457-62.

    Not in our library10.1093/ageing/31.6.457

37. 37.

    Ohkubo K, Kato Y, Ichikawa T, et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer. 2002;94:2663-8.

    Not in our library10.1002/cncr.10557

38. 38.

    Ueno S, Tanabe G, Nuruki K, et al. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepato Pancreat Surg. 2002;9:469-77.

    Not in our library10.1007/s005340200058

39. 39.

    Kawakita T, Shiraki K, Yamanaka Y, et al. A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma. Int J Oncol. 2003;23:1115-20.

    Not in our library

40. 40.

    Nagaoka S, Yatsuhashi H, Hamada H, et al. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer. 2003;98:2671-7.

    Not in our library10.1002/cncr.11839

Cited by papers we hold 3

• Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database · 2021
  Not checked
• Transarterial chemoembolization with pirarubicin-eluting microspheres in patients with unresectable hepatocellular carcinoma: Preliminary results · 2019
  Not checked
• The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis. · 2018
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.